Across TCGA pan-cancer cohorts, RNU6-1001P RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated RNU6-1001P data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher RNU6-1001P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU6-1001P expression acts as an unfavorable survival marker, although some lineages such as PAAD show a favorable association.

SKCM, UCEC, and STAD are the cancer types where RNU6-1001P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	OS	Tertile	All	0.338	0.788	.003	45	view →
UCEC	DFS	Tertile	All	0.123	0.648	.008	18	view →
STAD	DFS	Tertile	All	0.433	0.662	.035	9	view →
PAAD	DFS	Tertile	All	1.000	0.267	.040	6	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

Exploration

Same gene, other analysis: RNU6-1001P tumor-vs-normal RNA expression · all RNU6-1001P data types